We have updated our privacy policy. If you have any question, contact us at privacy@scicrunch.org. Dismiss and don't show again

Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Fate mapping using Cited1-CreERT2 mice demonstrates that the cap mesenchyme contains self-renewing progenitor cells and gives rise exclusively to nephronic epithelia.

Developmental biology | Jan 1, 2008

Classic tissue recombination and in vitro lineage tracing studies suggest that condensed metanephric mesenchyme (MM) gives rise to nephronic epithelium of the adult kidney. However, these studies do not distinguish between cap mesenchyme and pre-tubular aggregates comprising the condensed MM, nor do they establish whether these cells have self-renewing capacity. To address these questions, we generated Cited1-CreER(T2) BAC transgenic mice, which express tamoxifen-regulated Cre recombinase exclusively in the cap mesenchyme. Fate mapping was performed by crossing these mice with the Rosa26R(LacZ) reporter line and evaluating the location and cellular characteristics of LacZ positive cells at different time points following tamoxifen injection. These studies confirmed expected results from previous in vitro analysis of MM cell fate, and provide in vivo evidence that the cap mesenchyme does not contribute to collecting duct epithelium in the adult. Furthermore, by exploiting the temporally regulated Cre recombinase, these studies show that nephronic epithelium arising at different stages of nephrogenesis has distinct spatial distribution in the adult kidney, and demonstrate for the first time that the cap mesenchyme includes a population of self-renewing epithelial progenitor cells.

Pubmed ID: 18061157 RIS Download

Mesh terms: Animals | Cell Lineage | Epithelial Cells | Humans | Kidney | Mesoderm | Mice | Mice, Transgenic | Nuclear Proteins | Stem Cells | Trans-Activators

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NICHD NIH HHS, Id: T32 HD007502
  • Agency: NIDDK NIH HHS, Id: P50 DK039261
  • Agency: NIDDK NIH HHS, Id: R21 DK064251
  • Agency: NIDDK NIH HHS, Id: R01 DK61558
  • Agency: NIDDK NIH HHS, Id: R21 DK064251-01S1
  • Agency: NIDDK NIH HHS, Id: R01 DK061558-05
  • Agency: NIDDK NIH HHS, Id: P50 DK39261
  • Agency: NIDDK NIH HHS, Id: R21 DK064251-01
  • Agency: NIDDK NIH HHS, Id: R01 DK061558
  • Agency: NIDDK NIH HHS, Id: R21 DK064251-02

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

We have not found any resources mentioned in this publication.